Annual Meeting and Alumni Reunion

Joseph B. Ciolino, MD (2009)
Associate Professor of Ophthalmology and Associate Director of Ophthalmology Alumni, Harvard Medical School
Henry Freeman Allen Cornea Scholar, Mass Eye and Ear

Eric Gaier, MD, PhD (2008, 2010)
Assistant Professor of Ophthalmology, Harvard Medical School
Site Director, Harvard Ophthalmology Residency Program, Boston Children’s Hospital 

Rachel Huckfeldt, MD, PhD (2013, 2016)
Assistant Professor of Ophthalmology, Harvard Medical School
Director, Inherited Retinal Degenerations Fellowship, Mass Eye and Ear

Joan W. Miller, MD (1989, 1991)
David Glendenning Cogan Professor of Ophthalmology and Chair of Ophthalmology, Harvard Medical School
Chief of Ophthalmology, Mass Eye and Ear and Mass General Hospital
Ophthalmologist-in-Chief, Brigham and Women’s Hospital

Joseph F. Rizzo III, MD (1986)
Simmons Lessell Professor of Ophthalmology and Director of Ophthalmology Alumni, Harvard Medical School
Director, Neuro-Ophthalmology Service, Mass Eye and Ear

In support of improving patient care, Boston Children’s Hospital is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. The course number is 220624-JA.

Physician

Boston Children’s Hospital designates this live activity for a maximum of 12 AMA PRA Category 1 Credits ™. Physicians should claim only credit commensurate with the extent of their participation in this activity.

Optometric CE

Boston Children’s Hospital designates this live activity for a maximum of 12 COPE credit hours. Optometrists should claim only the credit commensurate with the extent of their participation in the activity.

Fees associated with AMA PRA Category 1 Credits™ have been provided by the HMS Department of Ophthalmology. Fees associated with COPE credit hours have been provided by the HMS Department of Ophthalmology.

Learning Objectives

Upon completion of this course participants will be able to: (1) Recognize how understanding ophthalmic disease at a molecular level will guide new therapies, (2) Discuss therapeutic advances and new treatment paradigms in areas outside the scope of their own practice, (3) Describe advances in the diagnosis of ophthalmic disease, and (4) Discuss new innovations in the understanding and treatment of ophthalmic disease. 

Faculty Disclosures

Co-chairs

Joan W. Miller, MD – Disclosure pending.

Joseph R. Rizzo II, MD – No relevant financial relationships to disclose.

Joseph Ciolino, MD – No relevant financial relationships to disclose.

Rachel Huckfeldt, MD, PhD – No relevant financial relationships to disclose.

Eric Gaier, MD, PhD – No relevant financial relationships to disclose.

Continuing Education Reviewers/Approvers

Lesley Niccolini (CME) – No relevant financial relationships to disclose. 

Greg Durkin (Nursing) – No relevant financial relationships to disclose. 

Crystal Tom (Pharmacy) – No relevant financial relationships to disclose. 

Pamela Chamorro (Social Work) – No relevant financial relationships to disclose. 

Eugene D’Angelo (Psychology) – No relevant financial relationships to disclose. 

Stephen Shusterman (Dentistry) – No relevant financial relationships to disclose.